Quality of probiotic products for preterm infants: Contamination and missing strains

Marijn J. Vermeulen, Ad Luijendijk, Letty van Toledo, Anton H. van Kaam, Irwin K. M. Reiss

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)

Abstract

Probiotics are effective in reducing necrotising enterocolitis in preterm infants, but routine use is not generally adopted. We describe a safety issue concerning contamination by pathogenic bacteria and missing of labelled strains in a probiotic product widely used in neonatal care. We recommend all centres using probiotics in the care of vulnerable patients to consider product safety checks in addition to the quality reports of manufacturers. Meanwhile, clinicians and manufacturers should collaborate to define quality standards for probiotic products in clinical settings as long as specific international regulations are lacking.
Original languageEnglish
Pages (from-to)276-279
Number of pages4
JournalActa paediatrica (Oslo, Norway
Volume109
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020

Keywords

  • Infloran
  • contamination
  • necrotising enterocolitis
  • probiotics
  • safety

Cite this